Headache Outcomes After Treatment of Cerebral Arteriovenous Malformations: A Systematic Review and Meta-Analysis with Clinical Implications
Abstract
Arteriovenous malformations (AVMs) are abnormal connections between cerebral arteries and veins that lack an intervening capillary bed. Brain AVMs affect approximately 0.1% of the population and are diagnosed in 1.3 per 100,000 individuals annually, with equal prevalence among sexes. While intracerebral hemorrhage is the most common presentation, accounting for 50% of cases, headaches are also reported in 17-50% of patients, sometimes occurring before any bleeding occurs. These headaches may resemble migraines and often meet the diagnostic criteria for AVM-related headache as outlined in intracerebral hemorrhage D-3. Occipital AVMs, in particular, are linked to prominent visual symptoms and migraine-like features. Despite numerous reports connecting AVMs with headaches, the underlying pathophysiologic mechanism of this link remains speculative. Treatment options for AVMs include embolization, stereotactic radiosurgery, surgical resection, or combinations of these. While some studies show headache relief in 38-100% of treated patients, others report worse outcomes. To address these inconsistencies, we conducted a systematic review and meta-analysis to measure the impact of AVM treatment on headache intensity. A search of 3 databases up to September 2023 identified 15 eligible studies with 1459 patients. Significant heterogeneity (I² = 57%, P = 0.003) required a random-effects model. The pooled analysis showed a significant reduction in headaches after treatment (pooled odds…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 100,000 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.